Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

APO Medical Opportunities

+ Add to Watchlist

APOMOPP:LX

127.04 EUR 1.29 1.03%

As of 00:59:30 ET on 03/30/2015.

Snapshot for APO Medical Opportunities (APOMOPP)

Year To Date: +8.71% 3-Month: +8.48% 3-Year: +21.53% 52-Week Range: 99.15 - 129.48
1-Month: +0.52% 1-Year: +20.94% 5-Year: +15.81% Beta vs LUXXX: 0.60

Mutual Fund Chart for APOMOPP

No chart data available.
  • APOMOPP:LX 127.04
  • 1M
  • 1Y
Interactive APOMOPP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for APOMOPP

APO Medical Opportunities is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equities of companies from the health care sector.

Inception Date: 08-31-2005 Telephone: 352-260248-1 Tel
Managers: KAI BRUENING / HARALD SCHWARZ
Web Site: www.ipconcept.lu

Fundamentals for APOMOPP

NAV (on 2015-03-30) 127.04
Assets (M) (on 2015-03-30) 190.85
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for APOMOPP

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for APOMOPP

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 0.57
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.96

Top Fund Holdings for APOMOPP

Filing Date: 02/28/2015
Name Position Value % of Total
Novartis AG 67,083 5,965,511 3.190%
Bayer AG 34,384 4,525,560 2.420%
Abbott Laboratories 95,904 4,058,043 2.170%
GlaxoSmithKline PLC 186,477 3,964,540 2.120%
Amgen Inc 28,008 3,945,839 2.110%
BioMarin Pharmaceutical Inc 41,257 3,945,839 2.110%
Pfizer Inc 127,491 3,908,438 2.090%
Edwards Lifesciences Corp 27,385 3,253,915 1.740%
H Lundbeck A/S 176,970 3,141,711 1.680%
Sanofi 35,610 3,123,010 1.670%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil